McAnear Justin J.'s Form 4 filing
10x Genomics, Inc. (TXG) · filed Jul 6, 2021
- Accession no.
- 0001209191-21-045475
- Filed
- Jul 6, 2021
- Trade date
- Jul 1, 2021
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 8 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.92M. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| McAnear Justin J.CIK 0001786386 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2021 | Class A Common Stock | MOption exerciseAcquired | +10,000 | $5.04 | +$50,400 | 49,370 | Direct | |
| Jul 1, 2021 | Class A Common Stock | SSaleDisposed | −2,700 | $189.85F3 | −$512,595 | 46,670 | Direct | |
| Jul 1, 2021 | Class A Common Stock | SSaleDisposed | −2,800 | $190.66F4 | −$533,848 | 43,870 | Direct | |
| Jul 1, 2021 | Class A Common Stock | SSaleDisposed | −1,500 | $191.73F5 | −$287,595 | 42,370 | Direct | |
| Jul 1, 2021 | Class A Common Stock | SSaleDisposed | −800 | $192.95F6 | −$154,360 | 41,570 | Direct | |
| Jul 1, 2021 | Class A Common Stock | SSaleDisposed | −1,400 | $193.76F7 | −$271,264 | 40,170 | Direct | |
| Jul 1, 2021 | Class A Common Stock | SSaleDisposed | −700 | $194.81F8 | −$136,367 | 39,470 | Direct | |
| Jul 1, 2021 | Class A Common Stock | SSaleDisposed | −100 | $195.82 | −$19,582 | 39,370 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2021 | Class A Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 410,159 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
This transaction was executed in multiple trades at prices ranging from $189.24 to $190.18. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $190.25 to $191.22. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $191.32 to $192.29. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $192.32 to $193.31. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $193.38 to $194.35. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F8
This transaction was executed in multiple trades at prices ranging from $194.40 to $195.39. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.